These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 12743130)
1. Role of intraperitoneal chemotherapy in the front-line setting. Markman M J Clin Oncol; 2003 May; 21(10 Suppl):145s-148s. PubMed ID: 12743130 [TBL] [Abstract][Full Text] [Related]
2. Salvage therapy in ovarian cancer: is there a role for intraperitoneal drug delivery? Markman M Gynecol Oncol; 1993 Oct; 51(1):86-9. PubMed ID: 8244180 [TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal chemotherapy in the management of malignant disease. Markman M Expert Rev Anticancer Ther; 2001 Jun; 1(1):142-8. PubMed ID: 12113122 [TBL] [Abstract][Full Text] [Related]
5. Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer? Petignat P; du Bois A; Bruchim I; Fink D; Provencher DM Crit Rev Oncol Hematol; 2007 May; 62(2):137-47. PubMed ID: 17188887 [TBL] [Abstract][Full Text] [Related]
6. Current status of intraperitoneal therapy for ovarian cancer. Markman M Curr Opin Obstet Gynecol; 1993 Feb; 5(1):99-104. PubMed ID: 7678757 [TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal chemotherapy for ovarian carcinoma. Markman M Biomed Pharmacother; 1987; 41(8):420-4. PubMed ID: 3330457 [TBL] [Abstract][Full Text] [Related]
8. An update on the use of intraperitoneal chemotherapy in the management of ovarian cancer. Markman M Cancer J; 2009; 15(2):105-9. PubMed ID: 19390303 [TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel. Ozols RF; Bookman MA; du Bois A; Pfisterer J; Reuss A; Young RC Gynecol Oncol; 2006 Oct; 103(1):1-6. PubMed ID: 16904166 [No Abstract] [Full Text] [Related]
10. Intraperitoneal therapy of ovarian cancer. Markman M Semin Oncol; 1998 Jun; 25(3):356-60. PubMed ID: 9633848 [TBL] [Abstract][Full Text] [Related]
11. Point: Intraperitoneal chemotherapy in the management of ovarian cancer. Markman M J Natl Compr Canc Netw; 2004 Nov; 2(6):549-54. PubMed ID: 19780298 [TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal Therapy of Ovarian Cancer. Markman M Oncologist; 1996; 1(1 & 2):18-21. PubMed ID: 10387964 [TBL] [Abstract][Full Text] [Related]
13. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments. Kyrgiou M; Salanti G; Pavlidis N; Paraskevaidis E; Ioannidis JP J Natl Cancer Inst; 2006 Nov; 98(22):1655-63. PubMed ID: 17105988 [TBL] [Abstract][Full Text] [Related]
14. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents. Ozols RF J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247 [TBL] [Abstract][Full Text] [Related]
16. Is there a role for intraperitoneal chemotherapy in the management of ovarian cancer? Markman M Oncology (Williston Park); 2001 Jan; 15(1):93-8; discussion 103-5. PubMed ID: 11271985 [TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment. Markman M; Walker JL J Clin Oncol; 2006 Feb; 24(6):988-94. PubMed ID: 16461779 [No Abstract] [Full Text] [Related]
18. Intraperitoneal chemotherapy in ovarian cancer: an update. Runowicz CD Cancer J; 2008; 14(1):7-9. PubMed ID: 18303475 [TBL] [Abstract][Full Text] [Related]